F (ferrous sulphate) — Competitive Intelligence Brief

F (ferrous sulphate) (F (ferrous sulphate)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Iron supplement. Area: Hematology.

marketed Iron supplement Iron (Fe2+) for hemoglobin and myoglobin synthesis Hematology Small molecule

Target snapshot

F (ferrous sulphate) (F (ferrous sulphate)) — Abdelwahed, Mai Mahmoud Mohamed, M.D.. Ferrous sulphate provides bioavailable iron to replenish depleted iron stores and restore hemoglobin synthesis in iron-deficiency anemia.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
F (ferrous sulphate) TARGET	F (ferrous sulphate)	Abdelwahed, Mai Mahmoud Mohamed, M.D.	marketed	Iron supplement	Iron (Fe2+) for hemoglobin and myoglobin synthesis
ARM A : IV iron + epoietin zeta	ARM A : IV iron + epoietin zeta	Centre Francois Baclesse	marketed	Iron supplement + Erythropoiesis-stimulating agent (ESA)	Erythropoietin receptor (EPOR); iron as cofactor for hemoglobin synthesis
Intravenous iron supplementation	Intravenous iron supplementation	University of Pecs	marketed	Iron supplement	Iron (Fe2+/Fe3+) for hemoglobin and myoglobin synthesis
Ferrous sulphate	Ferrous sulphate	University of Lausanne	marketed	Iron supplement	Iron (Fe2+) for hemoglobin and myoglobin synthesis
Sucrosomial Iron	Sucrosomial Iron	Cardiochirurgia E.H.	marketed	Iron supplement
Daily Ferrous Sulfate	Daily Ferrous Sulfate	Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri	marketed	Iron supplement
Weekly Ferrous Sulfate	Weekly Ferrous Sulfate	Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri	marketed	Iron supplement	Iron (Fe2+) for hemoglobin synthesis

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Iron supplement class)

1. Tanabe Pharma Corporation · 4 drugs in this class
2. Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri · 2 drugs in this class
3. Universidade Federal Fluminense · 2 drugs in this class
4. Clinica Fabia Mater · 1 drug in this class
5. GlaxoSmithKline · 1 drug in this class
6. Hatem AbuHashim · 1 drug in this class
7. Hospital Universitari Vall d'Hebron Research Institute · 1 drug in this class
8. Laboratoire Innotech International · 1 drug in this class
9. Lee's Pharmaceutical Limited · 1 drug in this class
10. Milton S. Hershey Medical Center · 1 drug in this class